ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: This molecular event generates a chimeric BCR-ABL fusion oncoprotein endowed with a constitutive tyrosine kinase activity in LSCs in the initial chronic phase of CML [68–70].